Aemetis Q1 2026: Revenue Up 27%, But Balance Sheet Crisis Unchanged

What happened

Aemetis reported Q1 2026 revenue growth of 27% year-over-year and achieved positive gross profit, with increased dairy RNG production. However, these operational improvements do not address the company's severe balance sheet distress: negative equity of ~$305M, $286.7M of debt due within 12 months against a $95.7M market cap, and explicit SEC going-concern language. The positive results likely reflect better ethanol margins and incremental RNG ramp, but the core financial instability remains, with high-cost demand-payable revolvers and a reliance on tax credit monetization. The stock's minor post-release bounce (from $1.25 to $1.36) signals speculative relief, not a fundamental shift in the risk of restructuring or dilution. The news does not alter the view that equity is a distressed option-like claim with a high probability of permanent impairment.

Implication

Investors should not view this as a turnaround signal; any constructive thesis requires a clear refinancing or deleveraging event (e.g., India IPO proceeds, debt-for-equity swap) that is not yet evident. The company must generate sustained positive FCF to cover debt service and capex, a steep challenge given loss history.

Thesis delta

The Q1 results show modest operational improvement—revenue growth and positive gross profit—reducing some near-term cash burn concerns. However, the balance sheet overhang (debt due > market cap, negative equity) and going-concern risk remain unchanged; the thesis stays a STRONG SELL, as the new data does not address the capital structure crisis.